Abstract B21: Novel pateamine A analogs to target pro-survival proteins in chronic lymphocytic leukemia
Conclusions: We have successfully synthesized three new PatA analogs with potent anti-leukemia activities. These compounds hold promise for application to cancers with the right biological context, such as CLL, in which the leukemia cells are addicted to the sustained expression of short-lived oncoproteins for survival.Citation Format: Rong Chen, Mingzhao Zhu, Yuling Chen, Wesley Skillern, Qun Qin, William G. Wierda, Kenneth G. Hull, Daniel Romo, William Plunkett. Novel pateamine A analogs to target pro-survival proteins in chronic lymphocytic leukemia. [abstract]. In: Proceedings of the AACR Special Conference on Translational Control of Cancer: A New Frontier in Cancer Biology and Therapy; 2016 Oct 27-30; San Francisco, CA. Philadelphia (PA): AACR; Cancer Res 2017;77(6 Suppl):Abstract nr B21.
Source: Cancer Research - Category: Cancer & Oncology Authors: Rong Chen, Mingzhao Zhu, Yuling Chen, Wesley Skillern, Qun Qin, William G. Wierda, Kenneth G. Hull, Daniel Romo, William Plunkett Tags: Small Molecule Drugs Selectively Targeting Translation Specialized for the Cancer Cell Source Type: research
More News: Acute Leukemia | Addiction | Biology | Cancer | Cancer & Oncology | Cancer Therapy | Chronic Leukemia | Chronic Lymphocytic Leukemia | Conferences | Leukemia | Study